C T DOLLERY|D EMSLIE SMITH|J P SHILLINGFORD - JoVE Visualize

Showing results (81-90 of 235) with videos related to

Pageof 24

Sort By:

British Journal of Clinical Pharmacology|January 1, 1987

Effect of enalapril on the skin response to bradykinin in manR W Fuller, J B Warren, M McCusker, et al.

British Journal of Pharmacology|September 1, 1973

Assessment of selective beta-adrenoceptor blockade in manR H Briant, C T Dollery, T Fenyvesi, et al.

Agents and Actions|April 1, 1984

Local histamine release after immunological and non-immunological mast cell degranulation in vivoP W Ind, A Miyatake, D J Heavey, et al.

Thorax|June 1, 1981

Circulating catecholamines in exercise and hyperventilation induced asthmaP J Barnes, M J Brown, M Silverman, et al.

Clinical Pharmacology and Therapeutics|May 1, 1976

Atenolol in essential hypertensionM G Myers, G R Lewis, J Steiner, et al.

Clinical Pharmacology and Therapeutics|July 1, 1991

Assessment of MK-467, a peripheral alpha 2-adrenergic receptor antagonist, with intravenous clonidineJ B Warren, C T Dollery, D Sciberras, et al.

Lancet (London, England)|March 13, 1976

Deterioration of glucose tolerance in hypertensive patients on prolonged diuretic treatmentP J Lewis, E M Kohner, A Petrie, et al.

British Journal of Clinical Pharmacology|June 1, 1982

Duration of effect of single daily dose methyldopa therapyJ M Wright, M Orozco-Gonzalez, G Polak, et al.

British Journal of Pharmacology|December 1, 1987

Human calcitonin gene-related peptide activates adenylate cyclase and releases prostacyclin from human umbilical vein endothelial cellsD Crossman, J McEwan, J MacDermot, et al.

Postgraduate Medical Journal|January 1, 1976

Electrocardiographic surface mapping of the heart following myocardial infarction and the influence of beta-blockadeD S Reid, L J Pelides, J P Shillingford, et al.

Pageof 24

Showing results (81-90 of 235) with videos related to

Sort By:

Pageof 24

British Journal of Clinical Pharmacology|January 1, 1987

Effect of enalapril on the skin response to bradykinin in manR W Fuller, J B Warren, M McCusker, et al.

British Journal of Pharmacology|September 1, 1973

Assessment of selective beta-adrenoceptor blockade in manR H Briant, C T Dollery, T Fenyvesi, et al.

Agents and Actions|April 1, 1984

Local histamine release after immunological and non-immunological mast cell degranulation in vivoP W Ind, A Miyatake, D J Heavey, et al.

Thorax|June 1, 1981

Circulating catecholamines in exercise and hyperventilation induced asthmaP J Barnes, M J Brown, M Silverman, et al.

Clinical Pharmacology and Therapeutics|May 1, 1976

Atenolol in essential hypertensionM G Myers, G R Lewis, J Steiner, et al.

Clinical Pharmacology and Therapeutics|July 1, 1991

Assessment of MK-467, a peripheral alpha 2-adrenergic receptor antagonist, with intravenous clonidineJ B Warren, C T Dollery, D Sciberras, et al.

Lancet (London, England)|March 13, 1976

Deterioration of glucose tolerance in hypertensive patients on prolonged diuretic treatmentP J Lewis, E M Kohner, A Petrie, et al.

British Journal of Clinical Pharmacology|June 1, 1982

Duration of effect of single daily dose methyldopa therapyJ M Wright, M Orozco-Gonzalez, G Polak, et al.

British Journal of Pharmacology|December 1, 1987

Human calcitonin gene-related peptide activates adenylate cyclase and releases prostacyclin from human umbilical vein endothelial cellsD Crossman, J McEwan, J MacDermot, et al.

Postgraduate Medical Journal|January 1, 1976

Electrocardiographic surface mapping of the heart following myocardial infarction and the influence of beta-blockadeD S Reid, L J Pelides, J P Shillingford, et al.

Pageof 24